Eikon Therapeutics, Inc (EIKN) insider trading
Every open-market stock purchase and sale by Eikon Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $46.1M over the last 12 months (5 buys).
- Last insider buy: Column Group IV GP LP (Insider), $25.9M, 8 months ago.
Last 12 months: insiders bought $46.1M (5 buys) and sold $0 (0 sales). Last close $8.96 on Jun 4, 2026.
Recent EIKN insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 2, 2026 | Roger M Perlmutter (Insider) | Bought (not open market) | — |
| Mar 2, 2026 | Kenneth C Frazier (Insider) | Bought (not open market) | — |
| Mar 2, 2026 | Robert Luther Huffines (Insider) | Bought (not open market) | — |
| Mar 2, 2026 | Michael A Klobuchar (COO) | Bought (not open market) | — |
| Mar 2, 2026 | Alfred Lloyd Bowie Jr. (CFO) | Bought (not open market) | — |
| Mar 2, 2026 | Benjamin Bruno Thorner (Insider) | Bought (not open market) | — |
| Mar 2, 2026 | Roy D. Baynes (C-suite exec) | Bought (not open market) | — |
| Feb 6, 2026 | Column Group IV GP LP (Insider) | Bought | $25.9M |
| Feb 6, 2026 | Column Group IV GP LP (Insider) | Bought | $11.4M |
| Feb 6, 2026 | Column Group IV GP LP (Insider) | Bought | $892K |
| Feb 6, 2026 | Josh Wolfe (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Josh Wolfe (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Josh Wolfe (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Josh Wolfe (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Column Group IV GP LP (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Lux Venture Partners V LLC (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Josh Wolfe (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Josh Wolfe (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Josh Wolfe (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Lux Venture Partners V LLC (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Lux Venture Partners V LLC (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Lux Venture Partners V LLC (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Lux Venture Partners V LLC (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Lux Venture Partners V LLC (Insider) | Bought (not open market) | — |
| Feb 6, 2026 | Lux Venture Partners V LLC (Insider) | Bought (not open market) | — |
Who's trading EIKN
- Roy D. Baynes, C-suite exec: other filings, last Mar 2, 2026
- Alfred Lloyd Bowie Jr., CFO: other filings, last Mar 2, 2026
- Robert Luther Huffines, Insider: other filings, last Mar 2, 2026
- Michael A Klobuchar, COO: other filings, last Mar 2, 2026
- Roger M Perlmutter, Insider: other filings, last Mar 2, 2026
- Benjamin Bruno Thorner, Insider: other filings, last Mar 2, 2026
- Kenneth C Frazier, Insider: bought $2M (1 buy), last Mar 2, 2026
- Column Group IV GP LP, Insider: bought $38.1M (3 buys), last Feb 6, 2026
- Josh Wolfe, Insider: bought $2.5M (1 buy), last Feb 6, 2026
- Lux Venture Partners V LLC, Insider: bought $2.5M (1 buy), last Feb 6, 2026
- Foresite Capital Management IV LLC, 10% owner: bought $1M (1 buy), last Feb 4, 2026
Get free alerts when an insider at Eikon Therapeutics, Inc files a new trade →